Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aes-103 in stable sickle cell disease
NCT01987908Phase 2Terminated
- Sponsor
- Takeda
- Start
- Dec 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-hydroxymethylfurfural in sickle cell disease (SCD), sponsored by Takeda. Started Dec 2013; status: terminated.
02
Drugs
5-hydroxymethylfurfural
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01987908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987908.